Cyril Amarchand Mangaldas Advises Tarsons Products

Cyril Amarchand Mangaldas advised Tarsons Products Limited (“Tarsons India”), on the acquisition of acquired 2 (two) German entities, Nerbe R&D Gmbh and Nerbe Plus Gmbh & Co. KG (“German Entities”), through Tarsons India’s wholly owned subsidiary, Tarsons Life Sciences Pte. Ltd. (“Tarsons Singapore”), for a valuation of EUR 10,000,000 (Euro Ten Million), as a going concern basis. For the transaction, Tarsons India infused funds through provision of a loan, for an amount up to EUR 13,000,000(Euro Thirteen Million) into Tarsons Singapore, where such funds would be utilised by Tarsons Singapore for the acquisition of the German Entities.

CAM played crucial role an provided guidance and assistance to Tarsons India, which involved navigating complex regulatory requirements related to overseas investments, evaluating and structuring guarantees, ensuring compliance with stock exchange regulation and facilitating necessary filings with relevant authorities.

The General Corporate team of Cyril Amarchand Mangaldas advised on the transaction.The transaction team was led by Soumya Srivastava, Partner; with support from Samaksh Khanna, Associate; and Vedaant Agarwal, Associate.

Other advisors to the transaction included Deloitte Germany, acted as International legal counsel for Tarsons Products Limited.